Department of Otolaryngology

Medicine & Life Sciences

1. Taiwan 100%
2. Sudden Hearing Loss 95%
3. Sensorineural Hearing Loss 82%
4. Population 63%
5. Nasopharyngeal Carcinoma 50%
6. Salivary Gland Calculi 44%
7. Cochlear Implants 43%
8. Cohort Studies 43%
9. Nose 36%
10. Databases 32%
11. Myringoplasty 29%
12. Trachea 27%
13. Neck 27%
14. Confidence Intervals 26%
15. Case-Control Studies 25%
16. Child 24%
17. Obstructive Sleep Apnea 24%
18. Neoplasms 23%
19. Otolaryngology 23%
20. Hydroxymethylglutaryl-CoA Reductase Inhibitors 23%
21. Ovalbumin 23%
22. Incidence 22%
23. Tympanoplasty 21%
24. Hearing 21%
25. Odds Ratio 21%
26. Health Insurance 21%
27. Head and Neck Neoplasms 20%
28. Hearing Loss 20%
29. Survival 19%
30. Allergic Rhinitis 19%
31. Radiotherapy 18%
32. Squamous Cell Carcinoma of Head and Neck 17%
33. Ear Canal 17%
34. ovatodiolide 16%
35. Cholesteatoma 16%
36. Otitis Media 16%
37. Logistic Models 15%
38. poly(lactide) 15%
39. Squamous Cell Carcinoma 15%
40. Neoplasm Metastasis 15%
41. Nasopharyngeal Neoplasms 14%
42. Therapeutics 14%
43. Down-Regulation 14%
44. Autophagy 14%
45. hesperetin 14%
46. Smartphone 14%
47. Temperature 14%
48. Sialadenitis 14%
49. Xylazine 14%
50. Mouth Neoplasms 14%
51. Smooth Muscle 14%
52. Solid-State Lasers 13%
53. Rolipram 13%
54. Carcinoma 13%
55. Tissue Engineering 13%
56. Comorbidity 13%
57. Salivary Glands 13%
58. Salivary Ducts 13%
59. Head 13%
60. Foreign Bodies 13%
61. Clear-cell metastatic renal cell carcinoma 12%
62. Histiocytic Necrotizing Lymphadenitis 12%
63. Sinusitis 12%
64. Tympanic Membrane Perforation 12%
65. Retrospective Studies 12%
66. Type 4 Cyclic Nucleotide Phosphodiesterase 12%
67. Zinc 12%
68. Parotid Gland 12%
69. Phosphodiesterase 4 Inhibitors 11%
70. Ketamine 11%
71. Tongue 11%
72. Transplants 11%
73. National Health Programs 11%
74. Mechanistic Target of Rapamycin Complex 1 11%
75. Electric Stimulation 11%
76. Systemic Lupus Erythematosus 11%
77. Bell Palsy 11%
78. Pediatrics 11%
79. Submandibular Gland 11%
80. Guinea Pigs 11%
81. Up-Regulation 10%
82. Vocal Cords 10%
83. Annexins 10%
84. Bone Conduction 10%
85. hesperetin-7,3'-O-dimethylether 10%
86. Laser Lithotripsy 10%
87. Audiometry 10%
88. Tension-Type Headache 10%
89. Retinal Vein Occlusion 10%
90. Facial Nerve 10%
91. Temozolomide 9%
92. Medicine 9%
93. Tonsillectomy 9%
94. Apoptosis 9%
95. Coronary Disease 9%
96. Triple Negative Breast Neoplasms 9%
97. Phosphoric Diester Hydrolases 9%
98. Nasal Obstruction 9%
99. Iron-Deficiency Anemias 9%